SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Dose-Response Study of N,N-Dimethyltryptamine in Humans
3 references·16 citing·36 second hop
Dose-Response Study of N,N-Dimethyltryptamine in Humans (1994)Dose-Response Study of N,N-Dimethyltrypta…Dose-Response Study of N,N-Dimethyltryptamine in Humans (1994)Dose-Response Study of N,N-Di…Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents (1984)Evidence for 5-HT2 involvemen…ADVERSE REACTIONS TO PSYCHEDELIC DRUGS. A REVIEW OF THE LITERATURE (1984)ADVERSE REACTIONS TO PSYCHEDE…Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms (2020)Psychedelics in Psychiatry: N…Cessation and reduction in alcohol consumption and misuse after psychedelic use (2019)Cessation and reduction in al…N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function (2018)N, N-Dimethyltryptamine (DMT)…Effects of psilocybin therapy on personality structure (2018)Effects of psilocybin therapy…DMT Models the Near-Death Experience (2018)DMT Models the Near-Death Exp…Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions (2018)Current perspectives on psych…Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness (2018)Ayahuasca: Psychological and …Modern Clinical Research on LSD (2017)Modern Clinical Research on L…Developing Guidelines and Competencies for the Training of Psychedelic Therapists (2017)Developing Guidelines and Com…Neuropharmacology of N,N-dimethyltryptamine (2016)Neuropharmacology of N,N-dime…Clinical applications of hallucinogens: A review. (2016)Clinical applications of hall…The hallucinogenic world of tryptamines: an updated review (2015)The hallucinogenic world of t…The behavioral pharmacology of hallucinogens (2007)The behavioral pharmacology o…Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids (2006)Risk assessment of ritual use…Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant (2006)Increased frontal and paralim…Human psychopharmacology of N,N-dimethyltryptamine (1995)Human psychopharmacology of N…Development of the Addiction Research Center Inventory (ARCI): Selection of items that are sensitive to the effects of various drugs (1963)Biochemical and histological evidence that methylenedioxymethylamphetamine (MDMA) is toxic to neurons in the rat brain. (1987)Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens (2011)Acute Effects of Lysergic Acid Diethylamide in Healthy Subjects (2014)Emotional breakthrough and psychedelics: Validation of the Emotional Breakthrough Inventory (2019)Hallucinogens (2004)Hallucinogens Recruit Specific Cortical 5-HT2A Receptor-Mediated Signaling Pathways to Affect Behavior (2007)Ayahuasca, dimethyltryptamine, and psychosis: a systematic review of human studies (2017)Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist action (1998)Looking for Spinoza: Joy, Sorrow, and the Feeling Brain (2004)Meditation experience is associated with increased cortical thickness (2005)Seeing with the eyes shut: Neural basis of enhanced imagery following ayahuasca ingestion (2011)The Therapeutic Potentials of Ayahuasca: Possible Effects against Various Diseases of Civilization (2016)Human Psychopharmacology of Hoasca, A Plant Hallucinogen Used in Ritual Context in Brazil (1996)Pharmacokinetics of Hoasca alkaloids in healthy humans (1999)Subjective effects and tolerability of the South American psychoactive beverage Ayahuasca in healthy volunteers (2001)Assessment of addiction severity among ritual users of ayahuasca (2010)Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews (2018)Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance (2006)Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer (2010)Modulation of Serum Brain-Derived Neurotrophic Factor by a Single Dose of Ayahuasca: Observation From a Randomized Controlled Trial (2019)NEO inventories for the NEO Personality Inventory-3 (NEO-PI-3), NEO Five-Factor Inventory-3 (NEO-FFI-3), NEO Personality Inventory-Revised (NEO PI-R) : professional manual (2010)The Epidemiology of Depression Across Cultures (2013)Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial (2016)Psychedelic Treatments for Psychiatric Disorders: A Systematic Review and Thematic Synthesis of Patient Experiences in Qualitative Studies (2020)The Therapeutic Potential of Psilocybin (2021)DSM-IV: Diagnostic and Statistical Manual of Mental Disorders (1994)Diagnostic and Statistical Manual of Mental Disorders (2013)Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD (2021)Broadband Cortical Desynchronization Underlies the Human Psychedelic State (2013)Increased Global Functional Connectivity Correlates with LSD-Induced Ego Dissolution (2016)Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function (2018)Psilocybin – Summary of knowledge and new perspectives (2013)Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years (2016)Long-term effects of psychedelic drugs: A systematic review (2020)Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up (2002)
this work references cited by second hop

References

  • 1984Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents631 cited
  • 1994Dose-Response Study of N,N-Dimethyltryptamine in Humans454 cited
  • 1984ADVERSE REACTIONS TO PSYCHEDELIC DRUGS. A REVIEW OF THE LITERATURE314 cited

Cited by

  • 2015The hallucinogenic world of tryptamines: an updated review291 cited
  • 2019Cessation and reduction in alcohol consumption and misuse after psychedelic use284 cited
  • 2016Neuropharmacology of N,N-dimethyltryptamine266 cited
  • 2018Effects of psilocybin therapy on personality structure266 cited
  • 1995Human psychopharmacology of N,N-dimethyltryptamine260 cited
  • 2006Risk assessment of ritual use of oral dimethyltryptamine (DMT) and harmala alkaloids243 cited
  • 2006Increased frontal and paralimbic activation following ayahuasca, the pan-amazonian inebriant241 cited
  • 2017Modern Clinical Research on LSD235 cited
  • 2020Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms231 cited
  • 2007The behavioral pharmacology of hallucinogens225 cited
  • 2017Developing Guidelines and Competencies for the Training of Psychedelic Therapists225 cited
  • 2018

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work

DMT Models the Near-Death Experience
221 cited
  • 2016Clinical applications of hallucinogens: A review.201 cited
  • 2018Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions190 cited
  • 2018Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness179 cited
  • 2018N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function177 cited